Chi Young Ok
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 39
- Acute Myeloid Leukemia Research 36
- Chronic Myeloid Leukemia Treatments 12
- Genetics 35
- Chronic Lymphocytic Leukemia Research 22
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Co-authors
- Ken H. YoungL. Jeffrey MedeirosSa A. WangThomas PapathomasKeyur P. PatelLing LiRajesh R. SinghMark J. Routbort
- Journals
- Modern Pathology (12 papers)Human Pathology (7 papers)Blood (7 papers)American Journal of Clinical Pathology (5 papers)Leukemia Research (4 papers)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Chi Young Ok
83 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 80
- Hematology 688
- Genetics 471
- Pathology and Forensic Medicine 539
- Oncology 588
- Immunology 241
Countries citing papers authored by Chi Young Ok
This map shows the geographic impact of Chi Young Ok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Young Ok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Young Ok more than expected).
Fields of papers citing papers by Chi Young Ok
This network shows the impact of papers produced by Chi Young Ok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Young Ok. The network helps show where Chi Young Ok may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Young Ok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 2 | |
| 15 | 2020 | 13 | |
| 16 | 2019 | 71 | |
| 17 | 2019 | 25 | |
| 18 | 2018 | 5 | |
| 19 | 2017 | 4 | |
| 20 | 2012 | 2 |
About Chi Young Ok
Chi Young Ok is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 88 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), Acute Myeloid Leukemia Research (36 papers), Chronic Lymphocytic Leukemia Research (22 papers), Viral-associated cancers and disorders (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Cancer Genomics and Diagnostics (10 papers) and Sarcoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Hematology (688 citations), Genetics (471 citations), Pathology and Forensic Medicine (539 citations), Oncology (588 citations) and Immunology (241 citations). Chi Young Ok has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Ken H. Young, L. Jeffrey Medeiros, Sa A. Wang, Thomas Papathomas, Keyur P. Patel, Ling Li, Rajesh R. Singh, Mark J. Routbort, Guillermo Garcia‐Manero and Rajyalakshmi Luthra. Their work appears in journals such as Modern Pathology, Human Pathology, Blood, American Journal of Clinical Pathology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.